Neuroprotective effect of recombinant human erythropoietin in experimental subarachnoid hemorrhage

Journal of Neurosurgical Sciences

Volumn 45, Issue 1, 2001, Pages 7-14

  Grasso, G ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

Glutamic acid neurotoxicity; Recombinant human erythropoietin; Subarachnoid hemorrhage; Vasoconstriction

Indexed keywords

GLUTAMIC ACID; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PLACEBO; RECOMBINANT ERYTHROPOIETIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BASILAR ARTERY; BRAIN ISCHEMIA; BRAIN PERFUSION; CISTERNA MAGNA; COMPUTER ASSISTED THERAPY; CONTROLLED STUDY; ENZYME ACTIVITY; HISTOPATHOLOGY; INTRACRANIAL ANEURYSM; MALE; MORPHOMETRICS; NEUROPROTECTION; NONHUMAN; RABBIT; SUBARACHNOID HEMORRHAGE; VASOCONSTRICTION;

ANIMALS; BRAIN ISCHEMIA; CEREBROVASCULAR CIRCULATION; DISEASE MODELS, ANIMAL; ERYTHROPOIETIN, RECOMBINANT; GLUTAMIC ACID; HUMANS; MALE; NEUROPROTECTIVE AGENTS; NITRIC OXIDE; RABBITS; SUBARACHNOID HEMORRHAGE; VASOCONSTRICTION;

EID: 0034928578     PISSN: 00264881     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. The time course of intracranial pathophysiological changes following experimental subarachnoid hemorrhage in the rat
2. Subarachnoid hemorrhage. Factors in prognosis and management
3. Cerebral vasospasm
4. Initial and recurrent bleeding are the major causes of death following subarachnoid hemorrhage
5. Brain lesion secondary to subarachnoid hemorrhage due to ruptured aneurysms
6. Time course of vasospasm in man
7. Cerebral perfusion, vascular spasm, and outcome in patients with ruptured intracranial aneurysms
8. Cerebral vasospasm following aneurysmal subarachnoid hemorrhage: Progress review
9. A primate model of subarachnoid hemorrhage: Change in regional cerebral blood flow, autoregulation carbon dioxide reactivity, and central conduction time
10. Sequential changes in cerebral blood low and metabolism in patients with subarachnoid haemorrhage
11. 99mTc-HMPAO tomography
12. P. Acute vasoconstriction after subarachnoid hemorrhage
13. Acute decrease in cerebral nitric oxide levels after subarachnoid hemorrhage
14. Elevation of extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis
15. Cellular origin of ischemia-induced glutamate release from brain tissue in vivo and in vitro
16. Effects of intravenous administration of recombinant human erythropoietin in rats subject to hemorrhagic shock
17. Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death
18. In vivo evidence that erythropoietin protects neurons from ischemic damage
19. Functional erythropoietin receptor of the cells with neural characteristics: Comparison with receptor properties of erythroid cells
20. A novel site of EPO production: Oxygen-dependent production in cultured rat astrocytes
21. Erythropoietin: Structure, control of production, and function
22. Liver as the primary site of erythropoietin formation in the fetus
23. Role of the kidney in erythropoiesis
24. Regulation of the erythropoietin gene: Evidence that the oxygen sensor is a heme protein
25. Immunohistochemical localization of erythropoietin and its receptor in the developing human brain
26. In vivo evidence that erythropoietin has a neuroprotective effect during subarachnoid hemorrhage
27. Pharmacokinetics of recombinant human erythropoietin in rabbits and 3/4 nephrectomized rats
28. Biphasic constriction of rabbit basilar artery following experimental subarachnoid hemorrhage: A morphometric study
29. A method for finding stereotaxic coordinates from brain sections
30. Clinical syndromes in cerebral thrombosis, hypertensive hemorrhage, and ruptured saccular aneurysm
31. The role of intracranial pressure in the arrest of hemorrhage in patients with ruptured intracranial aneurysm
32. Cerebral arterial flow dynamics during aneurysm haemorrhage
33. Intracranial pressure changes following primate subarachnoid hemorrhage
34. Hemodynamics of subarachnoid hemorrhage arrest
35. Cerebral edema following experimental subarachnoid hemorrhage
36. Cerebral pathology in subarachnoid hemorrhage
37. Morphometry of brain parenchymal vessels following subarachnoid hemorrhage
38. Physiological and morphometric analysis of microcirculation of the cerebral cortex under acute vasospasm
39. Pathogenetic role of no-reflow phenomenon in experimental subarachnoid hemorrhage in dogs
40. Effect of subarachnoid hemorrhage on microcirculation in hypothalamus and brain stem of dogs
41. Sub-pial infiltration of blood products following experimental subarachnoid haemorrhage
42. Endothelium-derived relaxing and contracting factors
43. Endothelial-derived relaxing and contracting factors
44. Alteration in endothelium-dependent responsiveness of the canine basilar artery after subarachnoid hemorrhage
45. Regulatory functions of the vascular endothelium
46. Impairment of endothelium-dependent relaxation in human basilar artery after subarachnoid hemorrhage
47. The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death
48. Ischemic flow threshold for extracellular glutamate increase in cat cortex
49. Erythropoietin prevents place navigation disability and cortical infarction in rats with permanent occlusion of the middle cerebral artery
50. Effect of erythropoietin on neuronal activity
51. A potential role for erythropoietin in focal permanent cerebral ischemia in mice
52. Brain capillary endothelial cells express two forms of erythropoietin receptor mRNA
53. Exposure of endothelial cells to recombinant human erythropoietin induces nitric oxide synthase activity
54. Hemodynamic effects of recombinant human erythropoietin